[1] 乔凯,陈嬿,吴志英,等. 肯尼迪病的电生理研究[J]. 中国临床神经科学, 2013, 21(3):312-316.
[2] Bertolin C, Querin G, Martinelli I, et al.Insights into the genetic epidemiology of spinal and bulbar muscular atrophy: prevalence estimation and multiple founder haplotypes in the Veneto Italian region[J]. Eur J Neurol, 2019, 26(3): 519-524.
[3] Fratta P, Nirmalananthan N, Masset L, et al.Correlation of clinical and molecular features in spinal bulbar muscular atrophy[J]. Neurology, 2014, 82(23): 2077-2084 .
[4] Lin X, Wu S.Bright tongue sign in Kennedy disease[J]. QJM, 2020, 113(1): 45-46.
[5] Querin G, Bertolin C, Da Re E, et al.Non-neural phenotype of spinal and bulbar muscular atrophy: results from a large cohort of Italian patients[J]. J Neurol Neurosurg Psychiatry, 2016, 87(8): 810-816 .
[6] Rosenbohm A, Hirsch S, Volk AE, et al.The metabolic and endocrine characteristics in spinal and bulbar muscular atrophy[J]. J Neurol, 2018, 265(5): 1026-1036 .
[7] Araki A, Katsuno M, Suzuki K, et al.Brugada syndrome in spinal and bulbar muscular atrophy[J]. Neurology, 2014, 82(20): 1813-1821 .
[8] Ni W, Chen S, Qiao K, et al.Genotype-phenotype correlation in Chinese patients with spinal and bulbar muscular atrophy[J]. PLoS One, 2015, 10(3): e01222796.
[9] Sussman J, Farrugia ME, Maddison P.Myasthenia gravis: association of British Neurologists’ management guidelines[J]. Pract Neurol, 2015, 15: 199-206.
[10] Pfeffer G, Chinnery PF.Diagnosis and treatment of mitochondrial myopathies[J]. Ann Med, 2013, 45(1): 4-16.
[11] Grunseich C, Rinaldi C, Fischbeck KH.Spinal and bulbar muscular atrophy: pathogenesis and clinical management[J]. Oral Dis, 2013, 20(1): 6-9. |
